This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
At Risk for HIV
and you are
between 18 and 30
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The goal of this Phase I study is to conduct a proof-of-concept trial of a contingency management (CM) targeting adherence to oral HIV antiretroviral pre-exposure prophylaxis (PrEP) administered via a smartphone-based medication adherence platform (PrEP SMART, "the app").

Provided treatments

  • Behavioral: PrEP Smart

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02895893. The sponsor of the trial is Duke University and it is looking for 12 volunteers for the current phase.
Official trial title: